Objective: Although breast conservation is therapeutically equivalent to mastectomy for most patients with early-stage breast cancer, an increasing number of patients are pursuing mastectomy, which may be followed by breast reconstruction. We sought to evaluate long-term quality of life and cosmetic outcomes after different locoregional management approaches, as perceived by patients themselves. Methods: We surveyed women with a diagnosis of nonmetastatic breast cancer from 2005 to 2007, as reported to the Los Angeles and Detroit populationbased Surveillance, Epidemiology, and End Results registries. We received responses from 2290 women approximately 9 months after diagnosis (73% response rate) and from 1536 of these 4 years later. We evaluated quality of life and patterns and correlates of satisfaction with cosmetic outcomes overall and, more specifically, within the subgroup undergoing mastectomy with reconstruction, using multivariable linear regression. Results: Of the 1450 patients who responded to both surveys and experienced no recurrence, 963 underwent breast-conserving surgery, 263 mastectomy without reconstruction, and 222 mastectomy with reconstruction. Cosmetic From the
R
andomized trials have established breast conservation as an equivalent alternative to mastectomy for most patients with earlystage breast cancer. 1 Nevertheless, a substantial minority of patients continue to receive mastectomy, a decision driven in some cases by patient preference and in others by contraindications to breast conservation. 2 Some studies indicate that in the United States, rates of unilateral 3, 4 and bilateral 5 mastectomy are rising. The reason for the increased use of mastectomy is uncertain, although it seems to be driven by patient choice, 2 and some have suggested that improved cosmetic outcomes with modern techniques of breast reconstruction may contribute to this trend. 6 The long-term quality of life (QOL) and cosmetic outcomes after different approaches can thus be an important consideration for patients when selecting a local therapy option for breast cancer treatment.
The patient's perception of cosmetic outcomes is a critical endpoint, 7 and measures of self-reported cosmetic outcomes are now increasingly incorporated into breast cancer clinical trial design. 8, 9 Although interest in patient-reported outcomes has grown in recent years, 10, 11 to date, the literature lacks information on patient-reported satisfaction with cosmetic outcomes of breast cancer treatment after the early postoperative period, particularly among breast cancer survivors who have received their care in a variety of settings and with a variety of therapeutic approaches.
Therefore, in a sample of breast cancer survivors identified through 2 metropolitan population-based cancer registries, we sought to describe QOL and long-term patient-reported satisfaction with cosmetic outcomes after breast cancer treatment. Specifically, we compared outcomes among those receiving breast reconstruction afsubset of patients receiving reconstruction, whether reconstruction type, timing, or patient characteristics were associated with cosmetic satisfaction. Because of the potential implications for clinical practice, we were particularly interested in evaluating the hypothesis that the influence of reconstruction type or timing on patient outcomes might differ in those patients who receive postmastectomy radiotherapy as compared with those who do not.
METHODS Sample
We conducted a longitudinal, multicenter cohort study of women with a diagnosis of breast cancer in metropolitan Los Angeles and Detroit. Patients aged 20 to 79 years and with a diagnosis of stage 0-III breast cancer between June 2005 and February 2007, as reported to the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) population-based program registries in those regions, were eligible for sample selection.
Patients were excluded if they had stage IV disease or could not complete a questionnaire in English or Spanish. Asian women in Los Angeles were excluded because of enrollment in other studies, as SEER protocol precludes patients from participating in more than 1 external study. Latina and black patients were oversampled to ensure sufficient minority representation.
Questionnaire Design and Content
We developed original questionnaires after considering existing literature, measures previously developed to assess relevant constructs, and theoretical models. [12] [13] [14] [15] We used standard techniques of content validation, including systematic review by design experts and cognitive pretesting with patients.
Data Collection
After institutional review board approval, eligible patients were identified via rapid case ascertainment. After notifying physicians, we first surveyed 3133 patients a mean of 9 months after diagnosis (time from diagnosis to baseline survey return: mean = 288 days, SD = 100). We then contacted all respondents approximately 4 years later to complete a follow-up survey (time from diagnosis to survey response: mean = 1524 days, SD = 143). To encourage response, we provided a $10 cash incentive at each survey point and used a modified Dillman 16 method, including reminders to nonrespondents, achieving 73% and 68% response rates, respectively. All materials were sent in English and Spanish to those with Spanish surnames. 17 Responses to the baseline and follow-up surveys were combined into a single data set, into which clinical data from SEER were merged. The evolution of the sample is detailed in Figure 1 .
Measures
We measured QOL using the validated FACT instrument, administered in the baseline and again in the follow-up survey. Our other key dependent variables were 2 measures of patient-reported satisfaction with cosmetic outcomes: one asked of all patients, and one specific to patients who received breast reconstruction (both derived from existing measures [12] [13] [14] [15] ); both were ascertained only in the follow-up survey to avoid assessing cosmetic outcomes soon after surgery. As more fully described in Supplementary Digital Content Appendix (available at http://links.lww.com/SLA/A618), the first measure (Satisfaction With Breast Cosmetic Outcomes) was a scale derived from a battery of questions posed to all patients, regardless of surgery type, that began by asking, "In the past 7 days, how satisfied have you been with . . . " and included items for "how you look in the mirror clothed, the shape of your breast(s) when you are wearing a bra, the shape of your breast(s) when you are not wearing a bra, how normal you feel in your clothes, how comfortably your bras fit, and how you look in the mirror unclothed." The mean of the scale was 3.33 (SD = 1.02), with a minimum of 1 and maximum of 5. The Cronbach α was 0.90, indicating high internal consistency in this scale.
The second measure of satisfaction (Satisfaction With Reconstruction Outcomes) was asked only of patients who reported that they had undergone breast reconstruction. Patients were asked to rate, from 1 (very dissatisfied) to 5 (very satisfied), their satisfaction with the overall results of reconstruction, reconstructed breast size, how natural the reconstructed breast(s) look, how the reconstructed breast(s) feel to touch, and how closely matched their breasts are to each other. The average of these 5 items was used to construct the scale. The scale ranged from 1 to 5, with a mean of 3.64 (SD = 1.27). The Cronbach α was 0.91, indicating high internal consistency.
We considered several independent variables based upon our conceptual models. For analysis of the entire cohort, the key independent variable of interest was surgery type (breast conservation, mastectomy without reconstruction, or mastectomy with reconstruction). For analysis of the reconstructed subset, the key independent variables were reconstruction type (autologous tissue vs implantbased) and timing (immediate-at the same time as mastectomy vs delayed). We also evaluated a number of other independent variables for inclusion in the models, based on our conceptual framework of the factors believed to be relevant. This included clinical factors: SEERreported tumor size (grouped in 10-mm increments) and nodal stage and self-reported adjuvant treatments (radiation and chemotherapy), laterality of the mastectomy (unilateral vs bilateral), comorbidities (grouped as 0, 1, and 2 or more of the following proxies for vascular risk: stroke, myocardial infarction, diabetes, or chronic obstructive pulmonary disease), smoking, body mass index, and bra cup size at the time of diagnosis. This also included several sociodemographic factors determined in the baseline questionnaire: age (continuous), race/ethnicity (non-Hispanic white, non-Hispanic black, Latina, or other), educational status (high school or less, some college, or college graduate), family income at diagnosis (<$20,000, $20,000-$70,000, >70,000, and unknown), insurance (none, Medicare, Medicaid, and other/private), and marital status (married or partnered vs not). Finally, we considered geographic site (Los Angeles vs Detroit) as an independent variable in the analyses.
Statistical Analyses
After initial descriptive analyses, we conducted a longitudinal evaluation of QOL by surgery type and used 2 separate multivariable linear regressions to model cross-sectional long-term satisfaction with cosmetic outcomes: one for all patients and one for patients who underwent reconstruction alone. To achieve parsimony of the regression models, we used a backward variable selection method to eliminate the variables that did not reach the statistical significance level of 0.10. However, we retained certain variables of particular interest in the models regardless of the statistical significance; these variables included the key independent variables being investigated in the models (surgery type in the first model, reconstruction type, and timing in the second) and control variables for age and the level of education for both models. In addition, driven by our hypotheses, we explored potential interactions between reconstruction type and radiation receipt and those between reconstruction timing and radiation receipt. Where evidence of meaningful interactions was observed, we investigated the difference among the 4 fully interacted subgroups in the regression model.
As selection and nonresponse. 18 Weighting allows statistical inferences to be more representative of the target population. The jackknife resampling method was used to obtain estimates that are robust toward nonnormal distributions. All analyses used SAS software, version 9.3 (SAS Institute, Cary, NC), and R package, version 2.13 (Vienna, Austria).
RESULTS
A total of 1536 patients completed both questionnaires; 86 were excluded because of tumor recurrence, leaving 1450 patients for the analysis of satisfaction with cosmetic outcomes. Table 1 presents the sociodemographic and clinical characteristics of the analyzed sample, along with treatments received. Median age was 58 years. A substantial proportion of the sample was black (17.3%) or Latina (39.5%). Educational attainment was high school or less for 42.2% of the sample, and 54.1% had stage 0 or I disease. The majority of patients (n = 963; 63%) underwent breast-conserving therapy, with the remainder fairly evenly divided between mastectomy alone (n = 263) and mastectomy with reconstruction (n = 222). Table 2 describes the QOL in our sample. We observed no significant differences in well-being by surgery type, except that there seemed to be a greater improvement in physical well-being by the time of the follow-up survey for patients who received mastectomy with breast reconstruction. Table 3 presents a multivariable linear regression model of the scaled measure of Satisfaction With Breast Cosmetic Outcomes in the 1245 patients with complete variable information. Satisfaction was not significantly different between the group receiving breast conservation and the group receiving mastectomy with reconstruction with either implant technique or autologous technique. Satisfaction was slightly but significantly lower (0.38) (worse on a 5-point scale; 95% confidence interval, −0.56 to −0.20) in patients receiving mastectomy alone than those who received breast conservation. Other correlates of lower satisfaction were chemotherapy receipt, higher body mass index, smoking, and lower family income. As Figure 2 Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. details, on the 5-point Satisfaction With Breast Cosmetic Outcomes scale, the adjusted scaled satisfaction score was 3.4 for patients receiving breast conservation, 3.6 for those receiving mastectomy with autologous reconstruction, 3.3 for patients receiving mastectomy with implant reconstruction, and 3.0 for patients receiving mastectomy without reconstruction. Of the 222 patients who received mastectomy and reconstruction, 200 had complete variable information and were further evaluated. There were 53 patients who received radiation therapy (among whom 54% had received reconstruction with autologous technique and 48% had delayed timing of reconstruction) and 147 who did not (among whom 23% had received reconstruction with autologous technique and 29% had delayed timing of reconstruction). Table 4 presents a linear regression model of the scaled measure of Satisfaction With Reconstruction Outcomes in patients who received mastectomy and reconstruction. We observed a substantial and statistically significant difference among 4 groups formed by the type of reconstruction procedure and receipt of radiation. In particular, patients who received implants with radiation had a markedly lower satisfaction than the patients in all other subgroups. The pattern across subgroups also suggested that satisfaction was higher for patients who received autologous reconstruction and those who did not receive radiation. As Figure 3 
Mastectomy without reconstrucƟon
Overall CosmeƟc SaƟsfacƟon FIGURE 2. Satisfaction with breast cosmetic outcomes by surgery type. It depicts adjusted scores on the scaled measure of satisfaction with breast cosmetic outcomes by the type of surgery received, based on results from the model described in Table 3 . Error bars represent 95% confidence intervals in comparison with the reference group (breast-conserving therapy). Satisfaction with breast cosmetic outcomes was measured by an interval scale derived the mean of 6 items, as described more fully in the "Methods" section. Mean (SD) of the scale was 3.33 (1.02), with a minimum of 1 and maximum of 5. The Cronbach α was 0.90.
With Reconstruction Outcomes scale, the adjusted scaled satisfaction score was 4.7 for patients receiving autologous reconstruction without radiation therapy, 4.4 for patients receiving autologous reconstruction and radiation therapy, 4.1 for patients receiving implant reconstruction without radiation therapy, and 2.8 for patients receiving implant reconstruction and radiation therapy. Thus, patients who received radiation and implant-based reconstruction had significantly lower satisfaction than those in the other 3 groups (those who received implant reconstruction without radiation, and those undergoing autologous reconstruction with or without radiation). We observed no significant association between timing of reconstruction and satisfaction with reconstruction outcomes, nor did we observe a significant interaction between timing and radiation receipt.
DISCUSSION
In this large sample of breast cancer survivors identified through metropolitan population-based registries, we found that QOL and long-term satisfaction with the cosmetic outcomes of breast cancer treatment overall were quite high. Breast reconstruction resulted in a level of patient-reported satisfaction with cosmetic outcomes in patients undergoing mastectomy that was statistically indistinguishable from that of patients who received breast-conserving therapy. 0 to 0 * Satisfaction with reconstruction outcomes was measured by an interval scale derived by the mean of 5 items, as described more fully in the "Methods" section. Mean (SD) of the scale was 3.64 (1.27), with a minimum of 1 and maximum of 5. The Cronbach α was 0.91. †Measured in patients who received breast reconstruction; 22 patients were not included because of missing values in dependent or independent variables. ‡Age centered about 60, such that every 1-year increase in age results in an average of a 0.02-unit decrease in satisfaction, and each 1-year decrease in age below 60 years results in a 0.02-unit increase in satisfaction.
BMI indicates body mass index; CI, confidence interval; SE, standard error.
FIGURE 3.
Satisfaction with outcomes of breast reconstruction by reconstruction type and receipt of radiation therapy. It depicts adjusted scores on the scaled measure of satisfaction with reconstruction outcomes, as measured in patients receiving breast reconstruction with various approaches, based on results from the model described in Table 4 . Error bars represent 95% confidence intervals in comparison to the reference group (implant no radiation). Satisfaction with reconstruction outcomes was measured by an interval scale derived the mean of 5 items, as described more fully in the "Methods" section. Mean (SD) of the scale was 3.64 (1.27), with a minimum of 1 and maximum of 5. The Cronbach α was 0.91.
Among patients undergoing breast reconstruction, satisfaction with outcomes of reconstruction at 4 years was higher in patients receiving autologous reconstruction and lower in patients receiving postmastectomy radiation therapy. Moreover, the differences in satisfaction between the locoregional treatment subgroups postmastectomy were substantial: patients who received autologous reconstruction without radiation reported on average that they were very satisfied (score 4.7/5), whereas those who received implants with radiation reported on average that they were dissatisfied (score 2.8).
Previous studies, primarily conducted in centers of excellence or in the context of clinical trials, have suggested that the vast majority of patients treated with breast-conserving therapy in those settings have good or excellent cosmetic outcomes. 19 The aesthetic results of breast conservation reflect the size and location of the surgical defect and scar and also late radiation changes to the skin. [20] [21] [22] Breast edema, which results from both surgery and radiation therapy, resolves in time for most patients but may persist for years. 23, 24 Fibrosis, again due to the interplay of surgical wound healing and reaction to radiotherapy, tends to manifest 6 to 18 months after treatment and may progress over time. 25 Among patients who do experience significant asymmetry as a result of such changes, QOL has been shown to be reduced. 26 Therefore, we found it particularly important in the current study to document the patient-reported QOL and cosmetic outcomes in a population of survivors treated in a broader variety of settings, at a time point after acute posttreatment changes have resolved. Our findings of high patient-reported satisfaction and few differences in QOL in this context are reassuring and do not support the notion that the recently observed increases in the rates of bilateral mastectomy for unilateral cancer are justified by poor cosmetic outcomes after breast-conserving therapy.
Our findings that the outcomes of breast reconstruction are similar to those of breast conservation, as experienced by patients treated in a variety of settings within 2 large and diverse metropolitan regions of the United States, are also reassuring. These findings Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. complement existing literature seeking to identify best practices and approaches toward reconstruction. For example, in one of the only multicenter studies of reconstruction outcomes reported from a US sample, aesthetic satisfaction at 2 years was higher in patients who had received autologous tissue-based reconstruction rather than implant techniques 15 and these differences seemed to increase over time. 27 Our findings support the idea that the use of autologous techniques for reconstruction is associated with improved satisfaction. In addition, in a population where a minority of women had contralateral prophylactic mastectomy, the high level of satisfaction with cosmetic outcomes and lack of significant association between receipt of bilateral mastectomy and satisfaction support the findings of a single-institution patient survey, in which no differences in satisfaction were observed between patients undergoing unilateral and bilateral mastectomy, 28 suggesting that contralateral prophylactic mastectomy is not necessary to achieve a good cosmetic outcome with breast reconstruction. The impact of radiation therapy on breast reconstruction is a subject of considerable interest. 29, 30 Radiation toxicity, including skin changes, vascular compromise, and fibrosis, can compromise the viability and cosmesis of the reconstruction and may require repeated interventions for correction. Previous retrospective studies have suggested that regardless of the type of reconstruction, radiation compromises cosmetic outcomes. [31] [32] [33] [34] [35] [36] Our results not only support this idea but also suggest that autologous techniques may mitigate some of the deleterious impact of radiotherapy on cosmetic outcomes. Taken together, this evidence supports counseling women in whom it is evident at the time of initial surgical evaluation that postmastectomy radiotherapy is likely to be necessary (those with a larger primary tumor or clinically positive nodes) about the potential for a suboptimal cosmetic outcome with reconstruction under this clinical scenario. Those who are candidates for breast conservation may reasonably choose to pursue that option instead.
The optimal approach to breast reconstruction in patients who do receive mastectomy and require postmastectomy radiotherapy for disease control continues to generate debate. 37 Complications in implant patients who receive radiotherapy include scarring, capsular contracture, infection, pain, skin necrosis, fibrosis, and impaired wound healing. [31] [32] [33] [34] Still, some institutions have reported excellent results using relatively uniform and carefully controlled approaches toward implant reconstruction in the setting of radiotherapy. 38, 39 Women undergoing radiation after autologous reconstruction face increased risks of fat necrosis, fibrosis, atrophy, and flap contracture. 35, 36 However, some clinicians believe that patients receiving radiation therapy may have better outcomes after autologous reconstruction than after implants 40 and have demonstrated good outcomes with such approaches. 41 However, estimates of the frequency of complications with different techniques and different sequences of radiation and reconstructive procedures have varied widely between different institutional series, and there is considerable need for patientreported outcomes data from patients treated across practices in the community. The current study begins to address this need, and its findings suggest that autologous approaches may indeed be superior in patients who receive radiotherapy. Its findings also suggest, consistent with other studies on utilization of reconstruction, 42 that autologous techniques may be used more frequently in patients receiving radiation therapy than those who do not, but a substantial proportion of patients receiving radiation therapy do receive implants. 42 Nevertheless, it is also important to consider limitations of this study. Of note, the number of patients who received reconstruction in this sample was substantial but not extremely large. Therefore, the lack of an observation of a statistically significant interaction between radiation receipt and timing of reconstruction is not evidence of the absence of such an effect. Given the sample size, the power to detect interaction effects was limited, and there may well be a differential impact of reconstruction timing in patients who received radiation therapy that this study was unable to detect. This does not, however, undercut the importance of findings such as the positive effect of autologous reconstruction on satisfaction, particularly in patients receiving radiotherapy. Still, given the number of patients receiving breast reconstruction in the overall sample, additional studies should be conducted to further validate these results. It is also important to note that as in all observational studies, associations may not indicate causation; however, given the impracticality of randomized trials to investigate these issues in the modern era, careful observational analysis may nevertheless yield insights. We have taken care to consider potential confounding factors and to obtain responses from a broad and more generalizable population than that achieved in singleinstitution studies. We cannot, however, control for the possibility that women electing breast reconstruction may have had greater baseline dissatisfaction with their breast size or shape.
CONCLUSIONS
The findings of this study provide reassuring evidence that QOL and satisfaction with cosmetic outcomes among breast cancer survivors overall are high. These results suggest that breast reconstruction allows patients undergoing mastectomy to have long-term satisfaction similar to that of patients undergoing breast conservation. Our findings regarding the deleterious impact of radiation on satisfaction after breast reconstruction may have implications for patient decision making, and the potential impact of autologous reconstruction in mitigating this effect merits further confirmation in independent, multicenter data sets. Patients' decisions about whether to pursue reconstruction and the specific type and timing of reconstruction should ideally be informed by rigorous, multicenter outcomes data such as those provided in this study.
